How does Charcot-Marie-Tooth (CMT) disease affect the treatment of other disorders?

Updated: Feb 19, 2019
  • Author: Francisco de Assis Aquino Gondim, MD, PhD, MSc, FAAN; Chief Editor: Nicholas Lorenzo, MD, MHA, CPE  more...
  • Print


Disease awareness on the part of the patient and health care providers is important. For example, development of cancer may lead to the consideration of neurotoxic drugs such as platinum compounds or vincristine. At times, other treatment protocols may be equally effective, at other times not. Also, colchicine for the treatment of gout may be avoided in favor of the much less (if at all) neurotoxic allopurinol.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!